Recent Conferences
October 14, 2010
Fall Forum
July 8, 2010
Summer Forum
April 15, 2010
Spring Forum
October 14, 2009
Accelerating High-Value Healthcare
September 16, 2009
Next Steps Toward a Robust Comparative Effectiveness Research Enterprise
July 20, 2009
Establishing a National Health Insurance Exchange
June 11, 2009
Federal Strategies for Promoting Affordable Biologics: Follow-On Biologic Competition
April 29, 2009
Implementing Bundled Payments for Health Care Services
November 24, 2008
Medicare Delivery System Reform
October 2, 2008
Specialty Pharmaceuticals: Policy Solutions for Encouraging Access and Affordability
July 16, 2008
Managing Specialty Pharmaceuticals
June 4, 2008
"Road Testing" Electronic Medical Records
April 30, 2008
Innovation Workgroup
April 10, 2008
Payment and Delivery System Reform
November 29, 2007
Comparative Effectiveness Congressional Briefing
November 27, 2007
Overview of Cost Management Strategies
October 24, 2007
Coverage With Evidence Development
October 2, 2007
Value-Based Payment for Medical Technologies
September 18, 2007
Personalized Medicine Conference
July 25, 2007
Comparative Effectiveness: Stakeholder Perspectives
April 11, 2007
Post Marketing Surveillance
February 14, 2007
Comparative Effectiveness Research: Congressional Briefing
November 30, 2006
Comparative Effectiveness Forum
October 12, 2006
Coverage Policy in an Era of Personalized Medicine
July 13, 2006
Pharmaceutical Benefit Management
May 1, 2006
Methodology Standards
April 4, 2006
Technology Assessment
October 3, 2005
Promoting Appropriate Utilization
April 1, 2005
Evidence-Based Health Care System
July 16, 2004
Correcting Underuse in Health Care
October 3, 2005
Promoting Appropriate Utilization in an Era of Increasing Patient Cost Sharing
There has been a substantial growth in the range of consumer directed health care plan (CDHP) products marketed to employers and individuals. A major concern about these products, however, is that large increases in cost sharing could cause individuals to forego necessary medical services, with the largest impact felt by those with lower incomes and chronic medical conditions. Because these programs are relatively new, limited evidence about their impact is currently available. This meeting examined how these programs are currently working with presentations from health plans and researchers examining the most recent utilization trends in these programs.
Presentations:
Comments on High Deductible Plans
Peter Juhn, M.D., Executive Director, Health Policy and Evidence-based Medicine, Johnson & Johnson
Stephen T. Parente, Ph.D., Assistant Professor, University of Minnesota
Consumer Directed Health Care and High Deductible Health Plans
John W. Rowe, M.D., Chairman & CEO, Aetna Inc.
What's Driving Consumer Directed Health Plans: Early Experience
Leonard D. Schaeffer, Chairman, WellPoint, Inc.
Implications of Increased Cost-Sharing for Consumers
Gail Shearer, Director of Health Policy, Consumers Union
Overview of Discovery's CDH Experience
Scott Spiker, President & CEO, Destiny Health
